6505--Tadalafil Tablets (VA-24-00107372)
ID: 36E79724R0033Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/bcc7fa4c68214a4bbc4b368cdc528938/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.

    Point(s) of Contact
    Billy FongContract Specialist
    (708) 786-4992
    billy.fong@va.gov
    Files
    Title
    Posted
    36E79724R0033_1.docx
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 regarding the procurement of Tadalafil Tablets. This unrestricted contract is intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor is expected to ensure a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions. Offerors must provide specific labeling information and adhere to packaging requirements, including safety features and dimensions for the bottles. The RFP will be launched on or about October 29, 2024, with proposals due by November 12, 2024. The estimated annual requirements include significant quantities of various Tadalafil strengths, totaling approximately 322,854 bottles. Interested parties can access documents and updates at sam.gov, and inquiries should be directed to Contract Specialist Billy Fong via email. This procurement aims to address the medication needs of veterans and other federal healthcare programs, ensuring compliance and quality service provision.
    Lifecycle
    Title
    Type
    6505--Tadalafil Tablets (VA-24-00107372)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0027 770-25-1-8-1-0015 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate pharmaceuticals, specifically 145 mg, under solicitation number 36C77025Q0027. The procurement involves delivering various quantities of the medication to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations, emphasizing compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and the Buy American Act. This initiative is crucial for ensuring timely access to essential pharmaceuticals for veterans, reflecting the VA's commitment to quality healthcare services. Interested vendors must submit their quotes, along with required documentation, by October 18, 2024, at 9:00 AM Central Time, with an anticipated award date of October 22, 2024. For further inquiries, vendors can contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    Pantoprazole DR Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE Pantoprazole DR Tablets: The Defense Logistics Agency is planning to issue a national requirements contract for Pantoprazole DR Tablets. These tablets, available in 20MG and 40MG strengths, will be provided in 90 and 1000 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The tablets will be purchased by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the solicitation. Interested parties can find more information on the DLA Bid Board System and Beta Sam.Gov websites. The solicitation is projected to be issued in September 2021.
    Pramipexole Tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is preparing to issue a solicitation for a national requirements contract for Pramipexole Tablets, which are essential medications used primarily for the treatment of Parkinson's disease and restless legs syndrome. The procurement will include various dosages of Pramipexole (0.125 MG, 0.25 MG, 0.5 MG, 0.75 MG, 1 MG, and 1.5 MG) packaged in 90 count bottles, and the contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. This acquisition is unrestricted and fully competitive, aimed at establishing a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should prepare for the solicitation, projected for October 2024, and may contact Ryan Guarnere at 215-737-2571 or Ryan.Guarnere@dla.mil for further inquiries.
    Rabeprazole Sodium Delayed Release Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0028 770-25-1-801-0018 -National CMOP METFORMIN HCL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking quotations for the emergency procurement of Metformin HCL 500mg 24HR SA Tablets, with a presolicitation notice issued under solicitation number 36C77025Q0028. The procurement involves multiple quantities of the medication to be delivered to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States, emphasizing the importance of timely and compliant pharmaceutical distribution to meet the needs of veterans. Interested vendors must submit their quotes, including a price schedule in Excel format, proof of state wholesale distributor licensure in compliance with the Drug Supply Chain Security Act, and other required documentation by October 21, 2024, at 09:00 AM CST, with an estimated award date of October 24, 2024. For further inquiries, vendors can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.